shutterstock_1416690755_jer123
27 March 2020CopyrightSarah Morgan

US $2tn coronavirus bill grants USPTO emergency powers

The US Patent and Trademark Office (USPTO) could be given emergency powers to waive or change patent and trademark filing deadlines if an historic $2 trillion deal passes the House of Representatives and is signed into law.

Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act, which the US Senate passed unanimously earlier this week, USPTO director Andrei Iancu would be able to temporarily “toll, waive, adjust, or modify, any timing deadline” to mitigate the impact of disruption caused by the COVID-19 pandemic.

To use this power, Iancu will need to determine that the emergency “materially affects” the functioning of the office, prejudices the rights of applicants, registrants, patent owners, or others appearing before the USPTO or prevents those appearing before the office from filing a document or paying a fee.

The emergency period is defined in the relevant  section as the national emergency declared by US President Donald Trump on March 13, 2020, as a result of the COVID-19 outbreak. Iancu’s authority would begin with the enactment of the CARES Act and end 60 days after the emergency period was over.

Maria Strong, in her capacity as acting register of copyrights, is also granted the ability to temporarily “toll, waive, adjust, or modify any timing provision” under copyright law (subject to certain exceptions).

The CARES Act was passed by the Senate on Wednesday, March 25. It has now been sent to the House of Representatives and, if it passes, will need to be signed into law by Trump. Despite some early stoppages by Senate Democrats, the bill is expected to pass and be signed into law.

Earlier this month, the  USPTO said it would waive petition fees in certain situations, amid the coronavirus pandemic. However, the office added that it is not granting waivers or extensions of dates or requirements set by statute, such as the period to file a patent application claiming the benefit of a prior­-filed foreign application.

In Europe, both the European Union Intellectual Property Office and the European Patent Office have  extended their deadlines.

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Copyright
1 April 2020   The US Patent and Trademark Office will waive certain trademark and patent filing and fee deadlines during the COVID-19 pandemic using its newly-acquired authority under the Coronavirus Aid, Relief, and Economic Security Act.
Trademarks
16 June 2020   The US Patent and Trademark Office has waived fees for trademarks covering COVID-19 medical products and services.
Patents
22 January 2021   The US Patent and Trademark Office engaged in “impermissible and unequal discussions” with information technology company Epsilon before awarding it a $47 million contract, according to the Government Accountability Office.